drugset / Trial / NCT04756180

An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.

NCT04756180

Phase 3 Completed 248 enrolled Abbott
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective was to investigate the effect of 12-week treatment of Omacor on fasting serum triglycerides (TG) in Chinese subjects with hypertriglyceridemia (HTG). The secondary objectives were to investigate the safety and tolerability and effect of Omacor on lipid parameters after 12 weeks treatment.

Timeline

Start
2016-10
Primary completion
2019-04
Completion
2019-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Lovaza Other / unclassified 4 g

Indications